Published in J Neurol Neurosurg Psychiatry on April 01, 1990
Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatry (1994) 0.89
Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06
Polymorphic hydroxylation of Debrisoquine in man. Lancet (1977) 9.36
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet (1980) 5.68
Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet (1986) 5.65
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature (1988) 3.69
Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection. J Chromatogr (1977) 2.43
Aetiology of Parkinson's disease. Lancet (1984) 2.32
A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin. Clin Pharmacol Ther (1985) 1.87
Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc Natl Acad Sci U S A (1988) 1.82
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun (1984) 1.81
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature (1984) 1.50
Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet (1985) 1.41
The influence of enzyme induction on polymorphic sparteine oxidation. Br J Clin Pharmacol (1986) 1.26
1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett (1984) 1.24
Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment. Pharmacol Toxicol (1987) 1.20
Xenobiotic metabolism in motor neuron disease. Lancet (1988) 1.16
Inhibitory effects of neuroleptics on debrisoquine oxidation in man. Br J Clin Pharmacol (1986) 1.13
MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochem Biophys Res Commun (1987) 1.05
Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22. Br J Clin Pharmacol (1987) 1.03
Xenobiotic and endobiotic inhibitors of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism. Biochem Pharmacol (1988) 0.97
Environmental and genetic factors in the etiology of Parkinson's disease. Adv Neurol (1987) 0.96
Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci (1987) 0.94
Debrisoquine metabolism in parkinsonian patients treated with antihistamine drugs. Lancet (1987) 0.85
[Stability and/or variability of the expression of genetic polymorphism of hydroxylation and acetylation in patients with various pathologies and under various treatments]. Ann Biol Clin (Paris) (1986) 0.82
Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B. J Neurochem (1985) 0.81
Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism? Neurosci Lett (1985) 0.81
Differences in the inhibitory effect of cimetidine on desipramine metabolism between rapid and slow debrisoquin hydroxylators. Clin Pharmacol Ther (1987) 0.80
Methyltetrahydro-beta-carbolines and Parkinson's disease. Lancet (1985) 0.80
Does an endogenous methylpyridinium analogue cause Parkinson's disease? J Pharm Pharmacol (1985) 0.79
Evidence for altered catalytic properties of the cytochrome P-450 involved in sparteine oxidation in poor metabolizers. Clin Pharmacol Ther (1987) 0.77
Federation of American Societies for Experimental Biology. 69th annual meeting, Anaheim, California, April 21-26, 1985. Abstracts of papers 8260-8843; 9001-9013. Fed Proc (1985) 0.77
Immunohistochemical localization of cytochrome P-450 in the rat brain. Neurosci Lett (1988) 0.77
[Genetic polymorphism of the hepatic metabolism of drugs]. Gastroenterol Clin Biol (1985) 0.77
Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease. Adv Neurol (1987) 0.76
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Randomized study comparing the "sniffing position" with simple head extension for laryngoscopic view in elective surgery patients. Anesthesiology (2001) 6.19
Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology (2000) 2.90
Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med (2001) 2.81
Repeated stress causes reversible impairments of spatial memory performance. Brain Res (1994) 2.55
Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. Nature (1993) 2.00
Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem (1998) 1.95
Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk. Carcinogenesis (2001) 1.94
The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61
DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis (2005) 1.54
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J (2005) 1.53
Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia (1999) 1.50
Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr (2009) 1.49
Low section of the rectum during laparoscopic total mesorectal excision using the Contour device. Technical report. Surg Endosc (2006) 1.48
QTL mapping of grain quality traits from the interspecific cross Oryza sativa x O. glaberrima. Theor Appl Genet (2004) 1.48
Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol (1995) 1.44
Postthymectomy wasting associated with autoimmune phenomena. I. Antiglobulin-positive anemia in A and C57BL-6 Ks mice. J Exp Med (1967) 1.44
Low IgG2 and polysaccharide response in a T cell receptor expression defect. Eur J Immunol (1990) 1.43
Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest (1993) 1.41
Folk diseases among urban Mexican-Americans. Etiology, symptoms, and treatment. JAMA (1966) 1.41
Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents. Clin Pharmacol Ther (1993) 1.38
The development and function of gamma delta T cells. Immunol Today (1990) 1.33
Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature (1990) 1.33
Balloon-expandable stent repair of severe coarctation of aorta. Am Heart J (1995) 1.29
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. J Immunol (1999) 1.26
Restraint stress reversibly enhances spatial memory performance. Physiol Behav (1996) 1.25
The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden. Blood (2001) 1.24
The immunologic competence of mouse thymus cells measured by the graft vs. host spleen assay. J Immunol (1966) 1.21
Functionally distinct subsets of human gamma/delta T cells. Eur J Immunol (1991) 1.21
Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev Infect Dis (1991) 1.21
Analysis of genetic variability and mapping of point mutations in influenza virus by the RNase A mismatch cleavage method. Proc Natl Acad Sci U S A (1988) 1.21
Interleukin 2 promotes growth and cytolytic activity in human T3+4-8- thymocytes. Proc Natl Acad Sci U S A (1985) 1.19
Debrisoquin oxidation polymorphism in a Spanish population. Clin Pharmacol Ther (1988) 1.18
Mapping of genes controlling aluminum tolerance in rice: comparison of different genetic backgrounds. Mol Genet Genomics (2002) 1.18
Manganese intoxication and chronic liver failure. Ann Neurol (1994) 1.18
The multicentre south European study 'Helios'. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.17
Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther (1995) 1.15
A suggested mechanism for T lymphocyte activation: implications on the acquisition of functional reactivities. Immunol Rev (1980) 1.15
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol (1994) 1.11
Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr (2006) 1.10
Inducible binding of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein (CREB) to a cAMP-responsive promoter in vivo. Mol Endocrinol (1999) 1.10
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med (Berl) (2001) 1.08
Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer (2006) 1.08
Dynamics of indigenous yeast populations during spontaneous fermentation of wines from Mendoza, Argentina. Int J Food Microbiol (2005) 1.08
Dynamics of Fusarium solani cutinase investigated through structural comparison among different crystal forms of its variants. Proteins (1996) 1.07
Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks. Antimicrob Agents Chemother (1990) 1.07
Thymic stroma is required for the development of human T cell lineages in vitro. Int Immunol (1989) 1.07
Microphthalmos with cyst: clinical presentations and computed tomographic findings. J Pediatr Ophthalmol Strabismus (1985) 1.07
Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. J Neuroimmunol (1996) 1.06
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. J Immunol (1999) 1.06
Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis. Clin Pharmacol Ther (1989) 1.05
Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann Oncol (2007) 1.05
Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci (1996) 1.04
Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden. Br J Clin Pharmacol (1995) 1.04
Anatomy of the gonadal veins: a reappraisal. Surgery (1991) 1.04
VIP-PACAP system in immunity: new insights for multitarget therapy. Ann N Y Acad Sci (2006) 1.03
Nerve root prolapse into a spinal arachnoid cyst--an unusual cause of radiculopathy. Clin Neurol Neurosurg (2009) 1.03
[Tuberculosis and diabetes mellitus: a longitudinal-retrospective study in a teaching hospital]. Rev Med Chil (1989) 1.03
Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock. Eur J Immunol (2000) 1.02
Establishment of idiotypic helper T-cell repertoires early in life. Nature (1985) 1.02
Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control (2010) 1.02
Immunology of VIP: a review and therapeutical perspectives. Curr Pharm Des (2001) 1.02
Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study. Heart (2009) 1.02
VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology (Oxford) (2005) 1.01
Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis (2006) 1.01
El hospital invisible. A study of Curanderismo. Arch Gen Psychiatry (1977) 1.01
Anatomo-radiological study of the Superior Semicircular Canal Dehiscence Radiological considerations of Superior and Posterior Semicircular Canals. Eur J Radiol (2009) 1.00
Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers. Pharmacogenetics (1996) 1.00
Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids. Epigenetics (2009) 1.00
Profile and competences for the European dentist. Eur J Dent Educ (2005) 1.00
The thymus in immunobiology: with special reference to autoimmune disease. Ann N Y Acad Sci (1965) 0.99
Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6. Acta Psychiatr Scand (1993) 0.99
Hematological and pathological changes induced in tolerant mice by the injection of syngeneic lymphoid cells. Transplantation (1968) 0.99
High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission. Bone Marrow Transplant (2004) 0.99
Contribution of cutinase serine 42 side chain to the stabilization of the oxyanion transition state. Biochemistry (1996) 0.98
Spontaneous mammary adenocarcinoma in mice: influence of thymectomy and reconstitution with thymus grafts or spleen cells. Cancer Res (1969) 0.98
Internal complementarities in the immune system: regulation of the expression of helper T-cell idiotypes. Proc Natl Acad Sci U S A (1984) 0.98
Transcription of the human corticotropin-releasing hormone gene in NPLC cells is correlated with Z-DNA formation. Proc Natl Acad Sci U S A (1996) 0.96
Yeasts associated to Malbec grape berries from Mendoza, Argentina. J Appl Microbiol (2005) 0.96
Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy. J Immunol (2001) 0.96
Secondary structure of the pore-forming colicin A and its C-terminal fragment. Experimental fact and structure prediction. Eur J Biochem (1985) 0.95
Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012. Ann Oncol (2010) 0.95
Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells. Rheumatology (Oxford) (2003) 0.95
Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP. Ann N Y Acad Sci (2000) 0.94
A role for T3+4-6-8- transitional thymocytes in the differentiation of mature and functional T cells from human prothymocytes. Proc Natl Acad Sci U S A (1986) 0.94
Reversal of post-thymectomy wasting disease in mice by multiple thymus grafts. J Immunol (1967) 0.94
Horse pancreatic lipase. The crystal structure refined at 2.3 A resolution. J Mol Biol (1994) 0.94
Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol (1998) 0.94
High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population. Eur J Clin Pharmacol (2001) 0.94
Distinct mechanisms contribute to generate and change the CD4:CD8 cell ratio during thymus development: a role for the Notch ligand, Jagged1. J Immunol (2001) 0.93
Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms. Br J Clin Pharmacol (1994) 0.93
Erythropoietin excretion in normal man. Blood (1966) 0.93
From apoptosis to autoimmunity: insights from the signaling pathways leading to proliferation or to programmed cell death. Immunol Rev (1994) 0.93
LRRK2 mutations are a common cause of Parkinson's disease in Spain. Eur J Neurol (2006) 0.92
T cell-dependent B cell activation. Immunol Rev (1984) 0.92
Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev (2000) 0.92
Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease. Br J Haematol (2001) 0.92